Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study

• Published in: Rheumatology (Oxford, England) England), 2021-05, Vol.60 (5), p.2391-2395
• Main Authors: Paalanen, Kirsi, Puolakka, Kari, Nikiphorou, Elena, Hannonen, Pekka, Sokka, Tuulikki
• Format: Article
• Language: English
• Subjects: Clinical Science
• ISSN: 1462-0324; 1462-0332
• DOI: 10.1093/rheumatology/keaa623

Abstract Objectives The classification of seronegative arthritides can be challenging. Our aim was to examine the incidence of SpA diagnosis among patients initially diagnosed as seronegative RA. Methods Using nationwide Finnish registers from social insurance institutions, we identified all adult patients who were diagnosed with incident seronegative RA [International Classification of Diseases (ICD)-10 code M06] from 1 January 2000 to 31 December 2014. The patients whose diagnoses subsequently changed to the ICD-10 codes of SpA (M07, M45, M46, K50 and K51) were identified in the national care register, until 31 December 2016. Results A total of 9784 adult seronegative RA patients were identified. Of these, 564 patients had their diagnosis subsequently changed to SpA: 275 (48.7%) patients with PsA, 245 (43.4%) patients with axial SpA and 44 (7.8%) patients with diagnoses related to IBD. The cumulative incidence of SpA diagnoses in 15 years was 10.4% (95% CI 8.9, 12.1) and 8.1% (95% CI 7.1, 9.3) in men and women, respectively. Conclusion This study calls for vigilance in seronegative RA patients, especially those with more atypical presentations, since the diagnosis could change. The possibility of SpA diagnosis should be considered and specifically looked for, as this could impact on management and response to treatment.